Sponsored

Senior support and better communicating the benefits of a long-term career in private markets could help reduce attrition among female investment staff, say Goldman Sachs’ Nicole Agnew and Stephanie Hui.

GPs need to focus on embedding diversity of thought at the firm and portfolio level, while ensuring culture change is led from the top, says Emily Pollock, solutions director at Schroders Capital.

An ageing population, an upgrading industry with strong innovation capability and a wave of venture capital investment means the Chinese market is well-positioned for increased healthcare interest, says Legend Capital’s Jafar Wang.

Home and community-based care, behavioural care and speciality pharma offer fresh opportunities for healthcare investors, say The Vistria Group’s co-heads of healthcare Jon Maschmeyer, Amy Christensen and David Schuppan.

Measuring progress on gender diversity must cover everything from recruitment and retention to the pay gap and career advancement, says Liz Campbell, managing director at Portfolio Advisors.

The private equity industry must take ownership of its diversity challenge if it wants to become more inclusive and relatable, say Investec’s Nicole Goodwin and Rebecca Moss.

Competition in healthcare is intense, but PE firms can succeed if they understand the post-covid ecosystem, say KPMG’s Kristin Pothier and Glenn Mincey.

The pandemic has heightened demand for some healthcare sectors while exposing fragility in others, says 3i director Severin Matten.

The secondaries market will continue on its growth trajectory and play an increasingly important role despite the threat of a market correction, says global co-head of private capital advisory at Jefferies, Scott Beckelman.

David Markson, a managing director with Evercore’s private capital advisory, explores the dynamics driving the strong LP secondaries market and how long they are likely to remain in play.